Cargando…
450. Type I Interferon Autoantibodies Are Detected in Those with Critical COVID-19, Including a Young Female Patient
BACKGROUND: Approximately 10-20% of patients with critical COVID-19 harbor neutralizing autoantibodies (auto-Abs) that target type I interferons (IFN), a family of cytokines that induce critical innate immune defense mechanisms upon viral infection. Studies to date indicate that these auto-Abs are m...
Autores principales: | Yee, Debra, Tso, Marana, Shaw, Elana, Rosen, Lindsey B, Samuels, Emily, Bastard, Paul, Casanova, Jean-Laurent, Holland, Steven M, Su, Helen C, Richard, Stephanie A, Mende, Katrin, Lalani, Tahaniyat, Lindholm, David A, Simons, Mark P, Tribble, David, Malloy, Allison, Laing, Eric, Agan, Brian, Pollett, Simon, Burgess, Timothy, Snow, Andrew L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690641/ http://dx.doi.org/10.1093/ofid/ofab466.649 |
Ejemplares similares
-
458. A Machine Learning Approach Identifies Distinct Early-Symptom Cluster Phenotypes Which Correlate with Severe SARS-CoV-2 Outcomes
por: Epsi, Nusrat J, et al.
Publicado: (2021) -
1352. A Precision Medicine Approach to Predicting “Long COVID” through Machine Learning Analysis of Whole Blood Transcriptome Data
por: Epsi, Nusrat J, et al.
Publicado: (2023) -
COVID-19 CHRONIC IMPAIRMENT WITH PULMONARY SYMPTOMS
por: GOERTZEN, STEPHEN M, et al.
Publicado: (2022) -
337. SARS-CoV-2 Viral Load Does Not Predict Incident Venous Thromboembolism in COVID-19
por: Pollett, Simon, et al.
Publicado: (2021) -
34. Long-term clinical outcomes following SARS-CoV-2 infection include persistent symptoms and cardiovascular disease beyond 3 months post-infection
por: Richard, Stephanie A, et al.
Publicado: (2021)